These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 16521479)

  • 21. The relationship between histopathological features of progressive supranuclear palsy and disease duration.
    Josephs KA; Mandrekar JN; Dickson DW
    Parkinsonism Relat Disord; 2006 Mar; 12(2):109-12. PubMed ID: 16337422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Widespread argentophilic structures in progressive supranuclear palsy--an autopsy case report].
    Hanihara T; Kubota H; Amano N; Yamaoka K; Yagishita S
    No To Shinkei; 1994 May; 46(5):487-92. PubMed ID: 8060688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pathology of the spinal cord in progressive supranuclear palsy.
    Vitaliani R; Scaravilli T; Egarter-Vigl E; Giometto B; Klein C; Scaravilli F; An SF; Pramstaller PP
    J Neuropathol Exp Neurol; 2002 Mar; 61(3):268-74. PubMed ID: 11895041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Divergent brain gene expression patterns associate with distinct cell-specific tau neuropathology traits in progressive supranuclear palsy.
    Allen M; Wang X; Serie DJ; Strickland SL; Burgess JD; Koga S; Younkin CS; Nguyen TT; Malphrus KG; Lincoln SJ; Alamprese M; Zhu K; Chang R; Carrasquillo MM; Kouri N; Murray ME; Reddy JS; Funk C; Price ND; Golde TE; Younkin SG; Asmann YW; Crook JE; Dickson DW; Ertekin-Taner N
    Acta Neuropathol; 2018 Nov; 136(5):709-727. PubMed ID: 30136084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
    Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
    Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Astrocytic tau pathology positively correlates with neurofibrillary tangle density in progressive supranuclear palsy.
    Ito K; Arai K; Yoshiyama Y; Kashiwado K; Sakakibara Y; Hattori T
    Acta Neuropathol; 2008 Jun; 115(6):623-8. PubMed ID: 18427815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation between clinical and neuropathological subtypes of progressive supranuclear palsy.
    Koizumi R; Akagi A; Riku Y; Miyahara H; Sone J; Tanaka F; Yoshida M; Iwasaki Y
    Parkinsonism Relat Disord; 2024 Oct; 127():106076. PubMed ID: 38494398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
    Ferrer I; Blanco R; Carmona M; Puig B
    J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adult-onset dementia with abundant neurofibrillary tangles resembling progressive supranuclear palsy].
    Hitoshi S; Mizutani T; Amano N; Bando M; Yamanouchi H
    Rinsho Shinkeigaku; 1994 Jun; 34(6):557-62. PubMed ID: 7955713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spatial topography of the neurofibrillary tangles in cortical and subcortical regions in progressive supranuclear palsy.
    Armstrong RA; Lantos PL; Cairns NJ
    Parkinsonism Relat Disord; 2007 Feb; 13(1):50-4. PubMed ID: 17046313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neurofibrillary pathology in progressive supranuclear palsy (PSP).
    Cervós-Navarro J; Schumacher K
    J Neural Transm Suppl; 1994; 42():153-64. PubMed ID: 7964685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement.
    Iwasaki Y; Mori K; Ito M; Tatsumi S; Mimuro M; Yoshida M
    Neuropathology; 2013 Oct; 33(5):561-7. PubMed ID: 23320789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurofibrillary tangles in progressive supranuclear palsy brains exhibit immunoreactivity to frameshift mutant ubiquitin-B protein.
    Fergusson J; Landon M; Lowe J; Ward L; van Leeuwen FW; Mayer RJ
    Neurosci Lett; 2000 Jan; 279(2):69-72. PubMed ID: 10674623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tau seeds from patients induce progressive supranuclear palsy pathology and symptoms in primates.
    Darricau M; Katsinelos T; Raschella F; Milekovic T; Crochemore L; Li Q; Courtine G; McEwan WA; Dehay B; Bezard E; Planche V
    Brain; 2023 Jun; 146(6):2524-2534. PubMed ID: 36382344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemical and ultrastructural characterization of neuritic clusters around ghost tangles in the hippocampal formation in progressive supranuclear palsy brains.
    Arima K; Nakamura M; Sunohara N; Nishio T; Ogawa M; Hirai S; Kawai M; Ikeda K
    Acta Neuropathol; 1999 Jun; 97(6):565-76. PubMed ID: 10378375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant accumulation of ErbB4 in progressive supranuclear palsy.
    Murakami A; Nakamura M; Kaneko S; Lin WL; Dickson DW; Kusaka H
    Neuropathol Appl Neurobiol; 2018 Oct; 44(6):563-573. PubMed ID: 29319907
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy.
    Katsuse O; Iseki E; Arai T; Akiyama H; Togo T; Uchikado H; Kato M; de Silva R; Lees A; Kosaka K
    Acta Neuropathol; 2003 Sep; 106(3):251-60. PubMed ID: 12802605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
    Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
    Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Silver stains distinguish tau-positive structures in corticobasal degeneration/progressive supranuclear palsy and in Alzheimer's disease--comparison between Gallyas and Campbell-Switzer methods.
    Uchihara T; Shibuya K; Nakamura A; Yagishita S
    Acta Neuropathol; 2005 Mar; 109(3):299-305. PubMed ID: 15619127
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inducible nitric oxide synthase (iNOS)-like immunoreactivity in argyrophilic, tau-positive astrocytes in progressive supranuclear palsy.
    Komori T; Shibata N; Kobayashi M; Sasaki S; Iwata M
    Acta Neuropathol; 1998 Apr; 95(4):338-44. PubMed ID: 9560010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.